IDE Voya Infrastructure Industrials and Materials Fund posts 25 YoY Q1 2026 revenue drop shares edge 022 lower today CanFite Bio CANF Future Outlook CANF Q4 2023 Earnings CanFite Biopharma Posts 962 EPS Beat 405B Revenue Neumora Therapeutics NMRA Stock Turns Bearish on Neumora Therapeutics NMRA 148 20260415 Battalion Oil BATL Stock Accumulation Buying Pressure 20260416 Columbia COLM Stock Sell Side Rating Climbs 20260418 Expeditors EXPD Trend Analysis Q4 2025 EPS Misses Views Market Recap Tech leads gains as consumer sector lags behind CAVA Group CAVA Market Leadership Q4 2025 EPS Tops Views Celldex CLDX Operational Review Q4 2025 Earnings Underperform ABLV Able View Global Inc posts 135 percent Q1 2025 year over year revenue decline stock edges higher